查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2024584

女性健康診斷市場報告：按類型、應用、最終用戶和地區分類（2026-2034 年）

Women's Health Diagnostics Market Report by Type, Application, End User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 150 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球女性健康診斷市場規模達331億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到561億美元，2026年至2034年的複合年成長率（CAGR）為5.86%。推動市場成長的因素包括：慢性病和文明病確診人數的增加、診斷服務技術的顯著進步、政府和公共部門透過眾多宣傳活動和舉措提高公眾對女性健康的認知、即時診斷技術的普及以及遠端醫療和遠距離診斷行業的快速發展。

女性健康診斷市場分析：

  • 主要市場促進因素：主要市場促進因素包括被診斷患有慢性疾病和文明病的患者數量不斷增加、重大技術進步以及人們對女性健康的日益重視。
  • 主要市場趨勢包括遠端醫療和遠距離診斷市場的快速成長、即時診斷技術的日益普及以及研發活動的增加。
  • 區域趨勢：北美憑藉其完善的醫療保健基礎設施和前沿的競爭格局，在女性健康篩檢產業中主導。歐洲則位居第二，這主要得益於慢性病患者數量的成長以及女性健康意識的提高。
  • 競爭格局：女性健康篩檢產業的主要參與者包括雅培實驗室、Aspira Women's Health、貝克頓·迪金森公司、生物梅里埃、Cefeid（丹納赫公司）、羅氏、通用電氣醫療、Hologic、皇家飛利浦、Quest Diagnostics、西門子醫療和賽默飛世爾科技。
  • 挑戰與機會：女性健康診斷市場近期的機會包括進入尚未開發的市場，以及個人化基因組學和個人化醫療的顯著進步。另一方面，挑戰包括診斷測試和設備的高昂成本，以及農村地區醫療設施的匱乏。

女性健康診斷市場趨勢：

被診斷出患有慢性疾病和文明病。

推動市場成長的主要因素之一是女性慢性病和文明病的日益普遍。這些疾病包括子宮頸癌、骨質疏鬆症、心血管疾病和乳癌。世界衛生組織（WHO）指出，乳癌是全球女性死亡的主要原因之一。 2022年，全球約有230萬名女性被診斷出罹患乳癌，其中67萬人死於此病。報告也指出，與人類發展指數（HDI）較低的國家相比，HDI較高的國家乳癌發生率相對較高。這些疾病盛行率的上升導致全球對女性健康診斷的需求不斷成長。導致這些疾病的主要原因之一是久坐不動的生活方式和不良的飲食習慣，這些因素也會導致肥胖和糖尿病等疾病。慢性病通常需要持續的監測和管理，這也推動了市場成長。此外，人們對早期檢測重要性的認知也不斷提高也發揮了重要作用。

政府措施的擴展

政府主導的旨在提高女性慢性病認知度的各項舉措，正對女性健康診斷市場產生正面影響。人們對女性特有的健康挑戰的認知和教育程度不斷提高，加上定期體檢的重要性日益凸顯，共同推動了市場的發展。為了實現這一目標，各國政府、非營利組織和公共機構紛紛進行宣傳活動，強調早期檢測和預防保健的重要性。其中，乳癌防治宣傳活動最為引人注目，其中一項便是每年十月舉行的「乳癌防治宣傳月」。這項活動始於1985年，由美國癌症協會和帝國化學工業公司（現為Astra Zeneca旗下子公司，阿斯特捷利康是領先的乳癌治療藥物生產商）攜手發起。該宣傳活動旨在提高大眾對乳癌的認知度，並為治療和研究資金籌措。在「乳癌防治宣傳月」期間，世界各地都會舉辦各種社群媒體宣傳活動、步行活動和跑步比賽。

即時診斷的廣泛應用

即時診斷技術的日益普及進一步推動了女性健康診斷市場的成長。這種診斷方法之所以被廣泛採用，是因為它能夠在患者附近進行診斷測試，從而獲得即時結果並加快臨床決策。這項技術在及時診斷對治療決策影響顯著的情況下尤其重要，例如妊娠併發症、癌症篩檢和性行為感染感染。根據IMARC GROUP發布的報告，2023年全球即時診斷市場規模達492億美元，預計2032年將達到995億美元，2024年至2032年的複合年成長率（CAGR）為7.9%。報告也指出，眾多領導企業正在合作提供獨特可靠的診斷解決方案，以變革醫療保健服務。例如，MOLBIO DIAGNOSTICS於2023年宣布與SIGTUPLE合作，共同開發用於多種常規和診斷測試的下一代人工智慧可攜式設備。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球女性健康診斷市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依類型

  • 診斷設備
    • 主要部分
      • 切片檢查裝置
      • 醫療影像和監測設備
      • 配件和耗材
  • 診斷測試
    • 主要部分
      • 乳癌篩檢
      • 子宮頸抹片檢查和HPV檢測
      • 懷孕測試和排卵測試
      • 其他

第7章 市場區隔：依應用領域分類

  • 乳癌
  • 傳染病檢查
  • 骨質疏鬆症檢測
  • 妊娠和不孕症檢查
  • 性行為感染感染檢測
  • 其他

第8章 市場區隔：依最終用戶分類

  • 醫院和診斷中心
  • 居家照護

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章 SWOT 分析

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Abbott Laboratories
    • Aspira Women's Health
    • Becton Dickinson and Company
    • bioMerieux
    • Cepheid（Danaher Corporation）
    • F. Hoffmann-La Roche Ltd
    • GE HealthCare
    • Hologic, Inc.
    • Koninklijke Philips NV
    • Quest Diagnostics
    • Siemens Healthineers AG
    • Thermo Fisher Scientific Inc.
Product Code: SR112026A4956

The global women's health diagnostics market size reached USD 33.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 56.1 Billion by 2034, exhibiting a growth rate (CAGR) of 5.86% during 2026-2034. The market is propelled by the rising number of individuals diagnosed with chronic and lifestyle-related diseases, significant technological developments in diagnostic services, increasing awareness about women's health through numerous campaigns and initiatives by the governments and public organizations, increasing acceptance rate of point-of-care diagnostics, and rapid growth in telemedicine and remote diagnostics industry.

WOMEN'S HEALTH DIAGNOSTICS MARKET ANALYSIS :

  • Major Market Drivers: Some of the major market drivers include the rising number of individuals diagnosed with chronic and lifestyle-related diseases, significant technological developments, and rising awareness and emphasis on the health of women.
  • Key Market Trends: Rapid growth of the telemedicine and remote diagnostics market, increasing adoption of point-of-care diagnostics, and increasing number of research and development (R&D) activities are some key market trends of the industry.
  • Geographical Trends: North America dominates the women's health diagnostics industry due to its robust health infrastructure and cutting-edge competition within the industry. Europe holds second position on account of the rising number of individuals diagnosed with chronic diseases and increasing awareness about women's health.
  • Competitive Landscape: Abbott Laboratories, Aspira Women's Health, Becton Dickinson and Company, bioMerieux, Cepheid (Danaher Corporation), F. Hoffmann-La Roche Ltd, GE HealthCare, Hologic, Inc., Koninklijke Philips N.V., Quest Diagnostics, Siemens Healthineers AG and Thermo Fisher Scientific Inc., are among some of the key players in the women's health diagnostics industry.
  • Challenges and Opportunities: Women's health diagnostics market recent opportunities include positioning in untapped markets and significant developments in personalized genomics and medicine. Whereas, challenges include expensive diagnostic tests and equipment and restricted access to healthcare facilities in rural regions.

WOMEN'S HEALTH DIAGNOSTICS MARKET TRENDS :

Substantial Rise in the Number of Females Diagnosed with Chronic and Lifestyle-Related Disorders

One of the primary factors driving the market is the increasing prevalence of chronic and lifestyle-related diseases amongst women. These include, cervical cancer, osteoporosis, cardiovascular diseases, and breast cancer. According to the WORLD HEALTH ORGANIZATION (WHO), breast cancer is one of the leading causes of death among women globally. Approximately 2.3 million women were diagnosed with breast cancer and 6,70,000 succumbed to it globally, in the year 2022. The report also states that in nations with an exceptionally high Human Development Index (HDI), the chances of occurrence of breast cancer is relatively high as compared to nations with a lower HDI. This increasing prevalence of these diseases is leading to a higher women's health diagnostics demand globally. One of the leading causes of these diseases is the sedentary lifestyles and poor dietary habits, which also lead to illnesses such as obesity and diabetes. Chronic illnesses usually require constant monitoring and management, thereby propelling the market growth. Other than this, the rising awareness about the importance of early detection is also playing a vital role.

Rising Government Initiatives

The rising government initiatives in order to spread awareness about the chronic illnesses prevalent amongst women, is creating a positive women's health diagnostics market overview. The increased awareness and education associated with the distinctive health challenges faced by women in confluence with the importance of regular health screenings is driving the market. In order to achieve this, governments, non-profit, and public organizations organize campaigns focusing on the importance of early detection and preventive care. One of the most renowned campaigns for breast cancer is the BREAST CANCER AWARENESS MONTH, which runs through the entire month of October. This initiative was started in the year 1985 through a productive collaboration between the AMERICAN CANCER SOCIETY and IMPERIAL CHEMICAL INDUSTRIES, which is ever since a part of ASTRAZENECA, a major producer of breast cancer medications. The campaign increases awareness around the disease and also raises funds for its treatments, and research. The awareness month includes numerous social media campaigns, walking events, and races taking place across the globe.

Rising Acceptance of Point-of-Care Diagnostics

The increasing acceptance of point-of-care diagnostics is further driving the women's health diagnostics market growth. The rising adoption of this type of diagnostics can be attributed to the advantage of conducing diagnostic tests nearby the patient, thereby offering immediate results and allowing faster clinical decision-making. This technique is majorly useful in cases where timely diagnosis can significantly impact treatment directions, such as in pregnancy-related complexities, cancer screenings, and sexually transmitted infections. According to a report published by the IMARC GROUP, the global point-of-care diagnostics market reached US$ 49.2 Billion in 2023, and is projected to reach US$ 99.5 Billion by 2032, reflecting a CAGR of 7.9% during 2024-2032. The report further mentioned numerous key players entering in partnerships in order to offer distinctive and dependable diagnostic solutions in order to transform the healthcare delivery. For instance, MOLBIO DIAGNOSTICS announced its collaboration with SIGTUPLE in the year 2023, for the development of next-generation AI-enabled movable devices for numerous routine and diagnostic tests.

WOMEN'S HEALTH DIAGNOSTICS INDUSTRY SEGMENTATION:

Breakup by Type:

  • Diagnostic Devices
    • Biopsy Device
    • Imaging and Monitoring Devices
    • Accessories and Consumables
  • Diagnostic Tests
    • Breast Cancer Testing
    • PAP Smear and HPV Test
    • Pregnancy Testing and Ovulation Testing
    • Others

Diagnostic Devices accounts for the majority of the market share

According to the women's health diagnostics forecast, diagnostic services dominate the market on account of the wide array of vital tests and screening possessed by them, which are important for early detection and management of numerous health conditions. Some of the most commonly available services include ultrasound, PAP smear tests, mammography, and blood tests which assist in the routine monitoring of specific conditions related to women's health. Other than this, the rising number of females suffering with chronic illnesses is leading to a rise in the demand for regular health check up drives, thereby creating a positive women's health diagnostics outlook. Moreover, the diagnostic services maintain a leading position within the industry also on account of the rising prevalence of the home diagnostic services. As per a market research report published by GITNUX, the global home diagnostics market is projected to reach USD 6.53 Billion by 201-2025.

Breakup by Application:

  • Breast Cancer
  • Infectious Disease Testing
  • Osteoporosis Testing
  • Pregnancy and Fertility Testing
  • Sexually Transmitted Disease Testing

Infectious disease testing holds the largest share in the industry

Infectious disease testing dominates the market growth on account of the rising number of sexually-transmitted infections (STIs) and numerous other communicable diseases. According to the WORLD HEALTH ORGANIZATION (WHO), more than 1 million individuals are diagnosed with sexually transmitted diseases (ATIs) every single day, globally. Majority of these diagnosed cases are asymptomatic. In order to seamlessly and effectively manage these conditions, there is a crucial requirement for appropriate management and treatment solutions. Other than this, the rising awareness amongst individuals regarding these conditions is also driving the infectious disease testing market. According to GITNUX, the infectious disease testing market is exhibiting a CAGR of 7% during 2021-2026. Moreover, governments and public organizations across the globe are taking initiatives to promote regular testing for these diseases.

Breakup by End User:

  • Hospital and Diagnostics Centers
  • Home Care

Hospital and diagnostics centers represent the leading market segment

Hospital and diagnostic centers represent the largest segment on account of their holistic healthcare services, developed diagnostic technologies, and capability to handle a high volume of patients. These services provide customized expertise and infrastructure for precise and early detection of complicated health conditions which seek effective treatment planning beforehand. Other than this, the rising number of hospitals globally is also a significant factor driving the market. According to the AMERICAN HOSPITAL ASSOCITION, there are 6,120 hospitals in the United States. These centers are usually the first point of care for numerous females seeking medical aid, which further contributes positively to the women's health diagnostic market revenue.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest women's health diagnostics market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America dominates the market on account of its robust healthcare infrastructure, presence of prominent key players and a significant rise in the healthcare expenditure across the United States. According to the AMERICAN MEDICAL ASSOCIATION (AMA), the health spending in the United States increased by 4.1% in 2022 to $4.4 Trillion or $13,493 per capita. The region particularly places a significant emphasis on early diagnosis and preventive care, in confluence with significant investment in research and development (R&D) activities thereby driving the market growth. Other factors driving the market include rising awareness campaigns, favorable reimbursement policies which further support the adoption of women's health diagnostics recent developments.

COMPETITIVE LANDSCAPE:

Major women's health diagnostics companies are significantly focusing on innovation and improving their product portfolios in order to improve diagnostic accuracy and efficiency. Additionally, they are also investing substantially in research and development (R&D) activities in order to launch advanced technologies including molecular diagnostics, AI-driven diagnostic tools, and next-generation sequencing. Prominent key players are also entering into strategic collaborations and acquisitions in order to enter untapped markets. For instance, in April 2023 QUEST DIAGNOSTICS and NEW YORK-PRESBYTERIAN announced that the former completes its acquisition fo selected assets of the laboratory services business of NEWYORK- PRESBYTERIAN. This strategic collaboration in meant to enable providers and patients to access good-quality, economical testing from a service menu that integrates the complementary strengths of both organizations.

The report provides a comprehensive analysis of the competitive landscape in the global women's health diagnostics market with detailed profiles of all major companies, including:

  • Abbott Laboratories
  • Aspira Women's Health
  • Becton Dickinson and Company
  • bioMerieux
  • Cepheid (Danaher Corporation)
  • F. Hoffmann-La Roche Ltd
  • GE HealthCare
  • Hologic, Inc.
  • Koninklijke Philips N.V.
  • Quest Diagnostics
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Women's Health Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Diagnostic Devices
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Biopsy Device
      • 6.1.2.2 Imaging and Monitoring Devices
      • 6.1.2.3 Accessories and Consumables
    • 6.1.3 Market Forecast
  • 6.2 Diagnostic Tests
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Breast Cancer Testing
      • 6.2.2.2 PAP Smear and HPV Test
      • 6.2.2.3 Pregnancy Testing and Ovulation Testing
      • 6.2.2.4 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Breast Cancer
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Infectious Disease Testing
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Osteoporosis Testing
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Pregnancy and Fertility Testing
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Sexually Transmitted Disease Testing
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospital and Diagnostics Centers
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Home Care
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Aspira Women's Health
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Becton Dickinson and Company
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 bioMerieux
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Cepheid (Danaher Corporation)
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 F. Hoffmann-La Roche Ltd
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 GE HealthCare
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Hologic, Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Koninklijke Philips N.V.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Quest Diagnostics
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Siemens Healthineers AG
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Thermo Fisher Scientific Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Women's Health Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Women's Health Diagnostics Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Women's Health Diagnostics Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Women's Health Diagnostics Market: Breakup by Type (in %), 2025
  • Figure 5: Global: Women's Health Diagnostics Market: Breakup by Application (in %), 2025
  • Figure 6: Global: Women's Health Diagnostics Market: Breakup by End User (in %), 2025
  • Figure 7: Global: Women's Health Diagnostics Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Women's Health Diagnostics (Diagnostic Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Women's Health Diagnostics (Diagnostic Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Women's Health Diagnostics (Diagnostic Tests) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Women's Health Diagnostics (Diagnostic Tests) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Women's Health Diagnostics (Breast Cancer) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Women's Health Diagnostics (Breast Cancer) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Women's Health Diagnostics (Infectious Disease Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Women's Health Diagnostics (Infectious Disease Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Women's Health Diagnostics (Osteoporosis Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Women's Health Diagnostics (Osteoporosis Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Women's Health Diagnostics (Pregnancy and Fertility Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Women's Health Diagnostics (Pregnancy and Fertility Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Women's Health Diagnostics (Sexually Transmitted Disease Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Women's Health Diagnostics (Sexually Transmitted Disease Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Women's Health Diagnostics (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Women's Health Diagnostics (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Women's Health Diagnostics (Hospital and Diagnostics Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Women's Health Diagnostics (Hospital and Diagnostics Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Women's Health Diagnostics (Home Care) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Women's Health Diagnostics (Home Care) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: North America: Women's Health Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: North America: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: United States: Women's Health Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: United States: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Canada: Women's Health Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Canada: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Asia-Pacific: Women's Health Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Asia-Pacific: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: China: Women's Health Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: China: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Japan: Women's Health Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Japan: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: India: Women's Health Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: India: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: South Korea: Women's Health Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: South Korea: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Australia: Women's Health Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Australia: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Indonesia: Women's Health Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Indonesia: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Others: Women's Health Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Others: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Europe: Women's Health Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Europe: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Germany: Women's Health Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Germany: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: France: Women's Health Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: France: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: United Kingdom: Women's Health Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: United Kingdom: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Italy: Women's Health Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Italy: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Spain: Women's Health Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Spain: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Russia: Women's Health Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Russia: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Others: Women's Health Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Others: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Latin America: Women's Health Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Latin America: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Brazil: Women's Health Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Brazil: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Mexico: Women's Health Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Mexico: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Others: Women's Health Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Others: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Middle East and Africa: Women's Health Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Middle East and Africa: Women's Health Diagnostics Market: Breakup by Country (in %), 2025
  • Figure 76: Middle East and Africa: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 77: Global: Women's Health Diagnostics Industry: SWOT Analysis
  • Figure 78: Global: Women's Health Diagnostics Industry: Value Chain Analysis
  • Figure 79: Global: Women's Health Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Women's Health Diagnostics Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Women's Health Diagnostics Market Forecast: Breakup by Type (in Million USD), 2026-2034
  • Table 3: Global: Women's Health Diagnostics Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 4: Global: Women's Health Diagnostics Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 5: Global: Women's Health Diagnostics Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Women's Health Diagnostics Market: Competitive Structure
  • Table 7: Global: Women's Health Diagnostics Market: Key Players